| Literature DB >> 33919227 |
Olalla Sáiz-Vázquez1, Patricia Gracia-García2, Silvia Ubillos-Landa3, Alicia Puente-Martínez4, Silvia Casado-Yusta5, Beatriz Olaya6,7, Javier Santabárbara7,8,9.
Abstract
Alzheimer's disease (AD) is the most frequent cause of dementia, linked to morbidity and mortality among elderly patients. Recently, several clinical studies suggested that depression is a potential risk factor for cognitive decline and AD. A review of meta-analyses was performed, calculating pooled odds ratios to estimate the risk of AD in people with a prior diagnosis (or clinically significant symptoms) of depression. A total of six meta-analyses which represented 28 individual studies were analyzed. A significant association between depression and AD was found (OR = 1.54, 95% CI [1.02-2.31]; p = 0.038). The results showed that heterogeneity across studies was substantial. We found a significant positive effect size for clinical measures of depression, but not for symptomatic rating scales, in the association of depression with risk of AD. The type of rating scale used to assess depression and the cut-off criteria selected also moderated the relationship between depression and AD risk. We found that studies that used clinically significant criteria for diagnosis of depression had more consistent and significant results than studies that used symptomatic scales.Entities:
Keywords: Alzheimer’s disease; clinical and symptomatic criteria; depression; meta-meta-analysis
Year: 2021 PMID: 33919227 DOI: 10.3390/jcm10091809
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241